100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in both
Our Recommendation
Healing Cough And Cold Tablet 10s
1,770+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Respiratory tract disorders associated with viscid mucus
Customers also bought
More About Kuffery Plus Tablet
Benefits
In Treatment of Respiratory tract disorders associated with viscid mucus Kuffery Plus Tablet helps to loosen thick mucus, making it easier to cough out. This makes it easier for air to move in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Take it as prescribed by the doctor. Do not stop using it unless you are advised to by your doctor. Taking this medicine enables you to live your life more freely without worrying so much about things that set off your symptoms.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
How to use Kuffery Plus Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Kuffery Plus Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Kuffery Plus Tablet is a mucolytic medication. It thins and loosens mucus (phlegm) in the nose, windpipe and lungs making it easier to cough out.
Unsafe: Avoid consuming alcohol with Kuffery Plus Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Kuffery Plus Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Kuffery Plus Tablet during breastfeeding is not available. Doctor consultation is advised.
Seek medical advice from your doctor: It is not known whether Kuffery Plus Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Caution Advised: Kuffery Plus Tablet should be used with caution in patients with kidney disease. Dose adjustment of Kuffery Plus Tablet may be needed. Doctor consultation is advised. Not recommended in patients with severe kidney disease. May cause excessive sleepiness in patients with end stage kidney disease.
Safe when prescribed by an expert: Kuffery Plus Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Kuffery Plus Tablet may not be needed in these patients. Doctor consultation is advised.
What if I forget to take it?
If a dose of Kuffery Plus Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
913, D-Mall,Netaji Subhash Place Pitampura New Delhi New Delhi DL 110034 IN
References
Drugs.com. Ambroxol (29 Apr. 2019)
Drugs.com. Guaifenesin (29 Apr. 2019)
Cetirizine. New York, New York: Pfizer Labs; 2003 (29 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
